Akira Nishizono

Akira Nishizono

Auto-generated profile, based on publicly available information

Akira Nishizono

Department of Microbiology, Faculty of Medicine, Oita University, Yufu, Japan

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 December 2015 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
KYKentaro Yamada
Kentaro Yamada
KNKazuko Noguchi
Kazuko Noguchi
TKTakashi Komeno
Takashi Komeno
YFYousuke Furuta
Yousuke Furuta
ANAkira Nishizono
Akira Nishizono
Rabies is a fatal encephalitis caused by rabies virus (RABV), and no antiviral drugs for RABV are currently available. We report for the first time the efficacy of favipiravir (T-705) against RABV in vitro and in vivo. T-705 produced a significant, 3–4 log10 reduction in the multiplication of street and fixed RABV strains in mouse neuroblastoma Neuro-2a cells, with half-maximal inhibitory concentrations of 32.4 µM and 44.3 µM, respectively. T-705 significantly improved morbidity and mortality among RABV-infected mice when orally administered at a dose of 300 mg/kg/day for 7 days, beginning 1 hour after inoculation. T-705 significantly reduced the rate of virus positivity in the brain. Furthermore, the effectiveness of T-705 was comparable to that of equine rabies virus immunoglobulin for postexposure prophylaxis. Collectively, our results suggest that T-705 is active against RABV and may serve as a potential alternative to rabies immunoglobulin in rabies postexposure prophylaxis.

29 May 2015 in Marine Drugs
Verified
Journal Article
Open access
PDF file
YSYuichiro Sato
Yuichiro Sato
KMKinjiro Morimoto
Kinjiro Morimoto
TKTakanori Kubo
Takanori Kubo
TSTakemasa Sakaguchi
Takemasa Sakaguchi
ANAkira Nishizono
Akira Nishizono
Kanji HoriKanji Hori
Kanji Hori
Lectin sensitivity of the recent pandemic influenza A virus (H1N1-2009) was screened for 12 lectins with various carbohydrate specificity by a neutral red dye uptake assay with MDCK cells. Among them, a high mannose (HM)-binding anti-HIV lectin, ESA-2 from the red alga Eucheuma serra, showed the highest inhibition against infection with an EC50 of 12.4 nM. Moreover, ESA-2 exhibited a wide range of antiviral spectrum against various influenza strains with EC50s of pico molar to low nanomolar levels. Besides ESA-2, HM-binding plant lectin ConA, fucose-binding lectins such as fungal AOL from Aspergillus oryzae and AAL from Aleuria aurantia were active against H1N1-2009, but the potency of inhibition was of less magnitude compared with ESA-2. Direct interaction between ESA-2 and a viral envelope glycoprotein, hemagglutinin (HA), was demonstrated by ELISA assay. This interaction was effectively suppressed by glycoproteins bearing HM-glycans, indicating that ESA-2 binds to the HA of influenza virus through HM-glycans. Upon treatment with ESA-2, no viral antigens were detected in the host cells, indicating that ESA-2 inhibited the initial steps of virus entry into the cells. ESA-2 would thus be useful as a novel microbicide to prevent penetration of viruses such as HIV and influenza viruses to the host cells.

1 December 2019 in Antiviral Research
Verified
Journal Article
Closed access
KYKentaro Yamada
Kentaro Yamada
KNKazuko Noguchi
Kazuko Noguchi
KKKazunori Kimitsuki
Kazunori Kimitsuki
RKRyo Kaimori
Ryo Kaimori
NSNobuo Saito
Nobuo Saito
ANAkira Nishizono
Akira Nishizono

SKSakirul Khan
Sakirul Khan
SASheikh Mohammad Akbar
Sheikh Mohammad Akbar
TYTakaaki Yahiro
Takaaki Yahiro
MMMamun Al Mahtab
Mamun Al Mahtab
KKKazunori Kimitsuki
Kazunori Kimitsuki
ANAkira Nishizono
Akira Nishizono
The outbreak of coronavirus disease 2019 (COVID-19) devastated the overall health management strategy of most countries. In this scenario, the present study provided insights into the possible impact of the COVID-19 pandemic on dengue infection. This ecological study retrieved data from WHO/Government reporting system from 22 major dengue epidemic countries. Incidence of dengue infections during the pre-COVID-19 time (2015~2019) and COVID-19 period (2020~2021) was compared. A correlation between the dengue and COVID-19 cases and predicted dengue incidence in 2022 was calculated using the linear regression equation. Data indicated that dengue incidences across the studied area decreased by 16% during the pandemic period (2.73 million vs. 2.29 million; p < 0.05) than the same reported in pre-COVID-19 time. Although countries in Latin America reported more cases than Asia, a positive correlation (r = 0.83) between dengue and COVID-19 cases was observed in Asia. Prediction analysis warned that specific preparation for dengue management is needed in some countries of both regions in 2022 to contain the upsurge in incidences. Due to the similar nature of symptoms of dengue and COVID-19, a state of confusion will be prevailing during the ongoing pandemic. Therefore, comprehensive and evidence-based scientific approaches were warranted at all levels.

5 November 2020 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
KKKazunori Kimitsuki
Kazunori Kimitsuki
NSNobuo Saito
Nobuo Saito
KYKentaro Yamada
Kentaro Yamada
CPChun-Ho Park
Chun-Ho Park
SISatoshi Inoue
Satoshi Inoue
ANAkira Nishizono
Akira Nishizono
Implementation of lateral flow devices (LFDs) for rabies antigen detection is expected to improve surveillance through the efficient detection of rabid animals in resource-limited settings; however, the use of LFDs for diagnosis remains controversial because some commercially available kits show low sensitivity. Therefore, we compared the diagnostic efficacy of three LFDs (ADTEC, Bionote, and Elabscience kits) paralleled with the direct fluorescent antibody test (dFAT) using fresh samples and investigated the diagnostic accuracies. To do so, we evaluated rabies-suspected samples submitted to the Regional Animal Disease Diagnostic Laboratory III, Philippines. Furthermore, we conducted real-time RT-PCR and sequencing to measure the accuracy of field laboratory diagnosis. The total number of animals submitted during this study period was 184 cases, including negative control samples. Of these, 53.9% (84 cases) were positive in the dFAT. Dogs were the most common rabies-suspected animal (n = 135). The sensitivities of the ADTEC and Bionote kits were 0.88 (74 cases) and 0.95 (80 cases), respectively. The specificity of both kits was 1.00 (100 cases). Furthermore, the sensitivity and specificity of the ADTEC kit after directly homogenizing the samples in assay buffer without dilution in phosphate-buffered saline (ADTEC kit DM) were 0.94 (79 cases) and 1.00 (100 cases), respectively. By contrast, there were no positive results using the Elabscience kit among all dFAT-positive samples. The sensitivity and specificity of LFDs make these tests highly feasible if properly used. Therefore, LFD tests can be used to strengthen the surveillance of rabies-infected animals in endemic and resource-limited settings.

6 February 2011 in Archives of Virology
Verified
Journal Article
Closed access
PDF file
TMTakashi Matsumoto
Takashi Matsumoto
KAKamruddin Ahmed
Kamruddin Ahmed
OWOmala Wimalaratne
Omala Wimalaratne
KYKentaro Yamada
Kentaro Yamada
SNSusilakanthi Nanayakkara
Susilakanthi Nanayakkara
ANAkira Nishizono
Akira Nishizono